Manganese Prussian blue nanozymes with antioxidant capacity prevent acetaminophen-induced acute liver injury-Reference-Cited by-同舟云学术

Manganese Prussian blue nanozymes with antioxidant capacity prevent acetaminophen-induced acute liver injury

Published:2023 Issue:7 Volume:11 Page:2348-2358
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Chen Chongqing¹,Wu Haitao²³,Li Qianhui⁴,Liu Menghua¹,Yin Fan¹,Wu Miaomiao²,Wei Xiaoli²,Wang Hua²,Zha Zhengbao³^ORCID,Wang Fei⁴

Affiliation:

1. School of Pharmacy, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei 230032, China

2. Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China

3. School of Food and Biological Engineering, Hefei University of Technology, Hefei 230009, China

4. China Guangdong Provincial Key Laboratory of Digestive Cancer Research and The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong 518107, China

Abstract

Manganese Prussian blue nanoparticles (MPBZs), bioactive antidotes for APAP poisoning, efficacious against APAP-induced liver injury (AILI) by inhibiting oxidative stress, suppressing hepatocyte apoptosis, and reducing inflammation.

Funder

Basic and Applied Basic Research Foundation of Guangdong Province

Shenzhen Science and Technology Innovation Program

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2023/BM/D2BM01968J

Reference40 articles.

1. Recommendations for the use of the acetaminophen hepatotoxicity model for mechanistic studies and how to avoid common pitfalls